↓ Skip to main content

Assessing the synergy between cholinomimetics and memantine as augmentation therapy in cognitive impairment in schizophrenia. A virtual human patient trial using quantitative systems pharmacology

Overview of attention for article published in Frontiers in Pharmacology, September 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

news
1 news outlet
twitter
1 X user

Readers on

mendeley
51 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Assessing the synergy between cholinomimetics and memantine as augmentation therapy in cognitive impairment in schizophrenia. A virtual human patient trial using quantitative systems pharmacology
Published in
Frontiers in Pharmacology, September 2015
DOI 10.3389/fphar.2015.00198
Pubmed ID
Authors

Hugo Geerts, Patrick Roberts, Athan Spiros

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 51 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 29%
Student > Ph. D. Student 9 18%
Student > Bachelor 5 10%
Other 4 8%
Student > Doctoral Student 2 4%
Other 6 12%
Unknown 10 20%
Readers by discipline Count As %
Psychology 12 24%
Neuroscience 6 12%
Medicine and Dentistry 6 12%
Agricultural and Biological Sciences 4 8%
Social Sciences 3 6%
Other 7 14%
Unknown 13 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 April 2024.
All research outputs
#3,796,095
of 25,808,886 outputs
Outputs from Frontiers in Pharmacology
#1,907
of 20,019 outputs
Outputs of similar age
#48,501
of 286,964 outputs
Outputs of similar age from Frontiers in Pharmacology
#21
of 98 outputs
Altmetric has tracked 25,808,886 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,019 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 286,964 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 98 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.